CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ClearPlasma is a filtration system that enhances human plasma for treating massive bleeding and bleeding disorders. By removing plasminogen, it improves coagulation and reduces the need for plasma transfusions, thus lowering treatment costs and improving patient outcomes.
Each year, almost 2 million people die from haemorrhaging, or blood loss.
Massive blood loss can occur upon:
Trauma, Surgery, Childbirth, Disseminated Intravascular Coagulation (DIC), Gastrointestinal Bleeding, etc.
In all of these cases, there is an urgent need for efficient plasma transfusion to halt the bleeding.
However, recent studies have shown that regular plasma fails to stop massive bleeding, while other treatments show low efficacy and increased mortality risk.ClearPlasma is an innovat…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
